Logo for Werewolf Therapeutics Inc

Werewolf Therapeutics Investor Relations Material

Latest events

Logo for Werewolf Therapeutics Inc

Study Update

Werewolf Therapeutics
Logo for Werewolf Therapeutics

Q4 2024

11 Mar, 2025
Logo for Werewolf Therapeutics

Q3 2024

7 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Werewolf Therapeutics Inc

Access all reports
Werewolf Therapeutics Inc. is a biopharmaceutical company focused on developing immunotherapies for cancer. The company specializes in engineered cytokine therapies designed to activate the immune system selectively within the tumor microenvironment. Its research and development efforts aim to enhance the efficacy and safety of immuno-oncology treatments through protein engineering and targeted delivery mechanisms. The company is headquartered in Watertown, Massachusetts, and its shares are listed on the NASDAQ.